What are the Historical Developments and Current Growth Metrics of the Personalized Cancer Treatment Market?
The personalized cancer treatment market has seen considerable growth due to a variety of factors.
• In recent times, the personalized cancer treatment market has seen a substantial increase in its size. An increase from $181.55 billion in 2024 to $201.57 billion in 2025 is anticipated, with a compound annual growth rate (CAGR) of 11.0%.
The notable growth within this historical timeframe could be due to advancements in the areas of genomics and molecular biology, an elevated incidence of cancer, increased adoption of personalized medicine, heightened awareness of the various cancer treatment alternatives, and the enhancement of cancer diagnostic and monitoring technologies.
What Is The Projected Growth Of The Personalized Cancer Treatment Template Market?
The personalized cancer treatment market is expected to maintain its strong growth trajectory in upcoming years.
• The market for personalized cancer treatments is projected to experience a substantial surge in the coming years. An exponential growth to $303.01 billion by 2029 is anticipated, with a compound annual growth rate (CAGR) of 10.7%.
The predicted growth within this period can be credited to the proliferation of targeted therapies, progress in AI and machine learning for treatment strategizing, escalated investments in cancer research, a rise in the need for precision medicine, and the discovery of novel biomarkers for customized treatment. During the forecast period, a significant rise in the application of combination therapies, increased incorporation of digital health mechanisms, growth in the preference for liquid biopsy techniques, wider availability of immunotherapy possibilities, and an enhanced emphasis on patient-focused treatment methods can be expected.
What Are The Key Drivers Fueling Growth In The Personalized Cancer Treatment Market?
The expansion of the personalized cancer treatment market is forecasted to be driven by growing cancer rates. This surge in cancer cases is mainly due to a rise in life expectancy, resulting in a greater number of individuals reaching cancer-prone ages and escalating exposure to risk factors like tobacco use, alcohol consumption, and obesity. Personalized cancer treatments offer efficient and targeted therapies for various types and stages of cancer, and this escalating burden incites investments and breakthroughs in precision medicine, with the goal of enhancing patient results through tailored treatment strategies. For example, as stated by the Switzerland-based World Health Organization, a United Nations agency committed to global health and safety, the worldwide cancer burden is anticipated to show a marked increase in February 2024. They anticipate a 77% growth in new cancer instances, climbing to over 35 million by 2050 from 20 million in 2022. Hence, the escalating prevalence of cancer is fueling the growth of the personalized cancer treatment market.
What Are The Principal Market Segments In The Global Personalized Cancer Treatment Industry?
The personalized cancer treatmentmarket covered in this report is segmented –
1) By Treatment Type: Targeted Therapy, Immunotherapy, Hormone Therapy, Chemotherapy, Radiation Therapy, Other Treatment Type
2) By Diagnostic Techniques: Genomic Sequencing, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization, Biomarker Testing, Other Diagnostic Techniques
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Cancer Types
4) By End-Users: Hospitals And Clinics, Research Institutes, Other End Users
Subsegments:
1) By Targeted Therapy: Monoclonal Antibodies, Small Molecule Inhibitors, Angiogenesis Inhibitors, Signal Transduction Inhibitors
2) By Immunotherapy: Checkpoint Inhibitors, CAR T-Cell Therapy, Cancer Vaccines, Monoclonal Antibodies For Immunotherapy
3) By Hormone Therapy: Anti-Estrogens, Aromatase Inhibitors, Progestins, LHRH Agonists
4) By Chemotherapy: Alkylating Agents, Antimetabolites, Anthracyclines, Taxanes
5) By Radiation Therapy: External Beam Radiation Therapy (EBRT), Brachytherapy, Radioimmunotherapy, Stereotactic Radiosurgery (SRS)
6) By Other Treatment Types: Gene Therapy, Stem Cell Transplantation, Metabolic Therapy, Nanomedicine
Pre-Book The Personalized Cancer Treatment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Personalized Cancer Treatment Market?
Leading businesses in the personalized cancer treatment sector are honing their focus on the creation of innovative solutions, like artificial intelligence (AI)-assisted multimodal immune profile algorithmic tests, to enhance the prediction of patient responses to immunotherapy and boost individualized treatment methodologies. This type of AI-augmented algorithmic test scrutinises a host of data forms, such as genomic, transcriptomic, and clinical biomarkers, in order to evaluate a patient's immune profile and predict their immunotherapy response, thus aiding the stratification of patients and direction of personalized cancer treatments. For example, in July 2024, US healthcare tech firm Tempus AI, Inc. launched its AI-assisted multimodal immune profile algorithmic test (IPS), its initial offering in the immunotherapy diagnostics sector. This test, meant solely for research purposes, measures various immunotherapy-related biomarkers to generate a score which supports the prediction of a patient's response to immunotherapy, thereby bolstering personalized cancer treatment strategies. These AI-powered diagnostics focused on immunotherapy enhance the stratification of patients and the selection of treatments in the field of oncology.
Who Are the Key Players In The Personalized Cancer Treatment Market?
Major companies operating in the personalized cancer treatment market are:
• Pfizer Inc.
• Johnson & Johnson
• F. Hoffmann-La Roche
• Merck & Co. Inc.
• Bristol Myers Squibb Company
• Thermo Fisher Scientific Inc.
• AstraZeneca Plc
• Novartis AG
• BioNTech SE
• Illumina Inc.
• Artera
• Exact Sciences Corporation.
• Moffitt Cancer Center
• Myriad Genetics
• NeoGenomics Laboratories
• Guardant Health
• Caris Life Sciences
• Tempus AI Inc.
• Foundation Medicine
• Immatics
• Fate Therapeutics
• CureVac AG
• TScan Therapeutics
• CureMetrix
• PDC*line Pharma
What Are The Regional Insights Into The Personalized Cancer Treatment Market?
North America was the largest region in the personalized cancer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
